Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY47.90 CNY
Change Today +0.80 / 1.70%
Volume 5.0M
600535 On Other Exchanges
Symbol
Exchange
Shanghai
As of 10:19 PM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

tasly pharmaceutical group-a (600535) Snapshot

Open
CNY47.17
Previous Close
CNY47.10
Day High
CNY48.19
Day Low
CNY47.00
52 Week High
04/14/15 - CNY51.43
52 Week Low
07/14/14 - CNY35.83
Market Cap
51.8B
Average Volume 10 Days
14.5M
EPS TTM
CNY1.37
Shares Outstanding
1.1B
EX-Date
--
P/E TM
35.0x
Dividend
CNY0.39
Dividend Yield
0.73%
Current Stock Chart for TASLY PHARMACEUTICAL GROUP-A (600535)

Related News

No related news articles were found.

tasly pharmaceutical group-a (600535) Related Businessweek News

No Related Businessweek News Found

tasly pharmaceutical group-a (600535) Details

Tasly Pharmaceutical Group Co., Ltd. engages in the manufacture and distribution of pharmaceutical products worldwide. Its herbal medicines include Danshen Plus capsules and CerebralCare granules; and chemical medicine comprise temozolomide, lisinopril, flutamide, and thiamphenicol capsules, as well as flutamide, sulpiride, glucurolactone, ketotifen fumarate, bezafibrate, tiapride hydrochloride, and metformin hydorchloride tablets. The company also offers health products, such as A1 capsules, citrus sour tablets, cordyceps, propolis and water lily, I-cleansing capsules, propolis and glossy ganoderma, red yeast, royal jelly softgel, de-toxin sheet, milk calcium, seal oil, and probiotics powder; tea; pharmaceutical substances and APIs; and herbal extracts. In addition, it provides cosmetic products, including moisture lotions and creams, eye creams, nourishing lotions, and face washing foams; daily hygiene products, such as soaps and sanitary pads; and medical equipment comprising B&E circulation machines, as well as massage cushions and tappers. Tasly Pharmaceutical Group Co., Ltd. was founded in 1994 and is based in Tianjin, China.

Founded in 1994

tasly pharmaceutical group-a (600535) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tasly pharmaceutical group-a (600535) Key Developments

Tasly Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter of 2015

Tasly Pharmaceutical Group Co., Ltd. reported earnings results for the first quarter of 2015. Basic earnings per share were CNY 0.3198. Weighted average return on net assets was 6.90%.

Tasly Pharmaceutical Group Co., Ltd. to Report Q1, 2015 Results on Apr 29, 2015

Tasly Pharmaceutical Group Co., Ltd. announced that they will report Q1, 2015 results on Apr 29, 2015

Tasly Pharmaceutical Group Co., Ltd., Board Meeting, Apr 27, 2015

Tasly Pharmaceutical Group Co., Ltd., Board Meeting, Apr 27, 2015. Agenda: To discuss and approve issues including the proposal of electing Yan Kaijing Chair of Directorate; to consider the proposal of renewing engagement of Zhu Yonghong as General Manager; and to consider the first quarter report of 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600535:CH CNY47.90 CNY +0.80

600535 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600535.
View Industry Companies
 

Industry Analysis

600535

Industry Average

Valuation 600535 Industry Range
Price/Earnings 36.3x
Price/Sales 3.9x
Price/Book 10.2x
Price/Cash Flow 37.9x
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TASLY PHARMACEUTICAL GROUP-A, please visit www.tasly.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.